Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2024Cancer

Out‐of‐pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured men

View Full Paper
Ask AI
Bookmark
Share

Authors

ASArnav SrivastavaATAnca TileaDKDavid D. Kim

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Srivastava et al. (2024) studied this question.

synapsesocial.com/papers/68e60461b6db643587597559https://doi.org/10.1002/cncr.35392
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MP57-02 OUT-OF-POCKET COSTS DOWNSTREAM OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED MEN2024
  2. 2Anticipated Out‐Of‐Pocket Costs and Prostate Cancer Management Among Men With Commercial Insurance2025
  3. 3Impact of repeated prostate-specific antigen testing on management patterns and personal healthcare spending for prostate cancer: A population-based study National Health Insurance data for 166,848 patients in South Korea from 2010 to 20202026
  4. 4The economic impact of opportunistic PSA screening: a real-world cost analysis from China amid evolving policy landscape2026
  5. 5Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT2026